Oxurion NV (EBR:OXUR)
Belgium
· Delayed Price · Currency is EUR 0.0056
-0.0004 (-6.67%)
Mar 9, 2026, 12:35 PM CET
Oxurion NV Revenue
Oxurion NV had revenue of 2.00K EUR in the twelve months ending June 30, 2025, down -97.62% year-over-year. In the year 2024, Oxurion NV had annual revenue of 3.00K, down -98.86%.
Revenue (ttm)
2.00K
Revenue Growth
-97.62%
P/S Ratio
196.28
Revenue / Employee
181.82
Employees
11
Market Cap
392.55K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.00K | -260.00K | -98.86% |
| Dec 31, 2023 | 263.00K | -332.00K | -55.80% |
| Dec 31, 2022 | 595.00K | -533.00K | -47.25% |
| Dec 31, 2021 | 1.13M | -950.00K | -45.72% |
| Dec 31, 2020 | 2.08M | -1.87M | -47.34% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioSenic | -2.39M |
| Celyad Oncology | 186.00K |
| European Medical Solutions | 49.47M |
| Hyloris Pharmaceuticals | 8.46M |
| Onward Medical | 2.72M |
| Financière de Tubize | 13.26K |
| argenx SE | 3.62B |
| UCB SA | 7.74B |